BOSTON SCIENTIFIC CORPORATION Deferred Revenue
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Revenue of $313.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-02-17
- 2025-12-31: Deferred Revenue, Current $313.00M.
- 2025-09-30: Deferred Revenue, Current $309.00M.
- 2025-06-30: Deferred Revenue, Current $313.00M.
- 2025-03-31: Deferred Revenue, Current $306.00M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2025-12-31 | $313.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $309.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $313.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $306.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $306.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $290.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $284.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $280.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $266.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $246.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $242.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $231.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $220.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $216.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $222.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $212.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $208.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $160.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $141.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $139.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $138.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $147.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $143.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $141.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $144.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $115.00M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |